The estimated Net Worth of Brik V Eyre is at least $10.9 Milion dollars as of 17 September 2018. Brik Eyre owns over 78,012 units of Baxter International stock worth over $2,316,655 and over the last 9 years Brik sold BAX stock worth over $8,562,058.
Brik has made over 5 trades of the Baxter International stock since 2017, according to the Form 4 filled with the SEC. Most recently Brik sold 78,012 units of BAX stock worth $6,031,108 on 17 September 2018.
The largest trade Brik's ever made was exercising 130,732 units of Baxter International stock on 8 May 2017 worth over $4,799,172. On average, Brik trades about 12,613 units every 22 days since 2015. As of 17 September 2018 Brik still owns at least 58,993 units of Baxter International stock.
You can see the complete history of Brik Eyre stock trades at the bottom of the page.
Brik's mailing address filed with the SEC is C/O BAXTER INTERNATIONAL, ONE BAXTER PARKWAY, DEERFIELD, IL, 60015.
Over the last 22 years, insiders at Baxter International have traded over $966,809,165 worth of Baxter International stock and bought 178,227 units worth $6,261,495 . The most active insiders traders include Point Llc Loeb Daniel S Third, Michael F Mahoney a Jeffrey A Craig. On average, Baxter International executives and independent directors trade stock every 37 days with the average trade being worth of $3,609,738. The most recent stock trade was executed by Jeanne K Mason on 1 March 2024, trading 64,488 units of BAX stock currently worth $2,397,019.
baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
Baxter International executives and other stock owners filed with the SEC include: